Stock Analyst Note
Bio-Rad Earnings: Modest Progress on Growth and Margin While Demand Remains Uneven
Bio-Rad reported year-on-year revenue growth of 0.7% at constant currency, its first quarter of growth this year, and non-GAAP operating margin rose 1 point to 12.8%. Management expects full-year currency-neutral revenue decline around 1.25% and margin in the upper half of its 10%-12% range.

